---
$id: https://graph.org.ai/products/commodity/51151626
$type: Product
source: UNSPSC
code: "51151626"
title: "Camylofin"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Camylofin

**UNSPSC Code**: 51151626
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a parasympatholytic with the molecular formula C19H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 340B6Q764V, chemically known as phenyldiethylaminoethyl-1-aminoacetic acid, isopentyl ester but generally known as camylofin, which bears US NIH Compound Identifier 5902. Camylofin most often comes in base and hydrochloride forms. European Medicines Agency schedules Camylofin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06068MIG. World Health Organization schedules camylofin in its Anatomical Therapeutic Chemical (ATC) Classification. CAMYLOFIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule camylofin under HS 29224995 and SITC 51465. As of Q4 2014, CAMYLOFIN remains the US FDA Preferred Term for this commodity. SMILES: O(CCC(C)C)C(=O)C(NCCN(CC)CC)C1CCCCC1.

